Streetbeat News

CAMP

CAMP4 Therapeutics Corporation

https://www.camp4tx.com/

Industry

Biotechnology

CAMP4 Therapeutics Corp. operates as a biotechnology company which engages in the discovery of treatment options for patients. The company was founded by Richard A. Young and Leonard Zon in 2015 and is headquartered in Cambridge, MA.

Open

9.96

Mkt cap

158M

Volume

41K

High

9.99

P/E Ratio

-3.18

52-wk high

12.30

Low

8.00

Div yield

N/A

52-wk low

7.80

During Friday's session, 157 stocks hit new 52-week lows. Among the notable companies were Corteva, American Rebel Holdings, Mullen Automotive, and BNY Mellon Strategic. The stocks that created new 52-week lows on Friday included Avangrid, SolarEdge Technologies, Etsy, UGI, Concentrix, Hawaiian Electric Indus, Equity Commonwealth, Forward Air, Cracker Barrel Old, Petco Health and Wellness, JinkoSolar Holding Co, Olaplex Hldgs, Frontier Group Holdings, Impinj, Safehold, Monro, 3D Sys, TDCX, Everbridge, Silk Road Medical, Cassava Sciences, 23andMe Holding, Wolverine World Wide, Avidity Biosciences, Boston Omaha, John Hancock Premium Div, BioLife Solns, Seres Therapeutics, American Well, Materialise, BNY Mellon Strategic, Southland Holdings, Funko, Fate Therapeutics, Citizens Financial Servs, American Lithium, Emergent BioSolutions, PetMed Express, Sutro Biopharma, Hippo Holdings, Largo, Omega Therapeutics, System1, Benson Hill, Eaton Vance Municipal, Vor Biopharma, Star Hldgs, Origin Mat, Joint, NanoString Technologies, Codexis, ContextLogic, Akoustis Technologies, Cano Health, GeneDx Hldgs, Electrovaya, Kezar Life Sciences, ProPhase Labs, Alaunos Therapeutics, Chimerix, Electriq Power Holdings, DZS, Streamline Health Solns, Eargo, Intercure, Prime Number Acquisition, REE Automotive, TD Hldgs, Carmell Therapeutics, Neuronetics, Kaixin Auto Hldgs, Crown Crafts, Airgain, Ohmyhome, Singular Genomics Sys, First Seacoast Bancorp, Sarcos Technology, Coya Therapeutics, Otonomo Technologies, CareCloud, Aterian, PAVmed, Orgenesis, CalAmp, Imperial Ptrl, Fitell, LQR House, Iridex, OMNIQ, Safeguard Scientifics, Lichen China, Origin Agritech, Atreca, Sunlight Finl Hldgs, Yunji, MediaCo Holding, Trio Petroleum, Cineverse, Lucy Scientific Discovery, Remark Hldgs, Shuttle Pharmaceuticals, Hempacco, Finch Therapeutics Gr, Visionary Education Tech, Marpai, Ontrak, Nogin, Adamis Pharmaceuticals, China Jo-Jo Drugstores, ABVC BioPharma, Fangdd Network Group, SeaStar Medical Holding, Yoshiharu Global, Universe Pharmaceuticals, Redhill Biopharma, Jiuzi Hldgs, Power REIT, Soligenix, Eightco Holdings, JanOne, Avalo Therapeutics, Yield10 Bioscience, Aditxt, Salarius Pharmaceuticals, China Pharma Holding, OpGen, Akanda, Harbor Custom Dev, Biocept, NeuBase Therapeutics, Ucommune International, INVO Bioscience, Esports Entertainment, American Rebel Holdings.

Portfolio Pulse from Benzinga Insights

August 11, 2023 | 6:01 pm

On Wednesday, 155 companies set new 52-week lows. The largest company by market cap to set a new 52-week low was Estee Lauder Cos (NYSE:EL). The smallest company by market cap to set a new 52-week low was SenesTech (NASDAQ:SNES). Siyata Mobile (NASDAQ:SYTA)'s stock fell the most, as it traded down 7658.62% to reach a new 52-week low. Sutro Biopharma (NASDAQ:STRO) was the biggest winner of the bunch, with shares actually trading up 0.0% after it rebounded from its new 52-week low.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 4:27 pm

The article lists five tech stocks that are currently oversold, according to the Relative Strength Index (RSI), and may present a buying opportunity. The companies are National Instruments Corporation (NATI), CalAmp Corp. (CAMP), WISeKey International Holding AG (WKEY), Neonode Inc. (NEON), and Powerbridge Technologies Co., Ltd. (PBTS). The stocks have RSI values below 30, indicating they may be undervalued.

Portfolio Pulse from Lisa Levin

July 20, 2023 | 11:24 am

During Tuesday's trading, 46 companies set new 52-week lows. The largest company by market cap to set a new 52-week low was TELUS (NYSE:TU). American Rebel Holdings (NASDAQ:AREB) was the smallest firm on a market cap basis to set a new 52-week low. 9 Meters Biopharma (NASDAQ:NMTR) was the biggest loser, trading down 68.25% to reach its 52-week low. Shuttle Pharmaceuticals (NASDAQ:SHPH) saw the sharpest rebound, as shares ascended 0.0%, reversing after hitting a new 52-week low.

Portfolio Pulse from Benzinga Insights

July 18, 2023 | 5:47 pm

Over the past 3 months, 6 analysts have published their opinion on CalAmp (NASDAQ:CAMP) stock. The average price target is $2.46, representing a 48.54% decrease from the previous average price target of $4.78. The ratings include 2 bullish, 1 indifferent, and 3 bearish.

Portfolio Pulse from Benzinga Insights

July 13, 2023 | 8:00 pm

Goldman Sachs analyst Jerry Revich maintains a Sell rating on CalAmp (NASDAQ:CAMP) and has lowered the price target from $2.75 to $0.8.

Portfolio Pulse from Benzinga Newsdesk

July 13, 2023 | 12:12 pm

During Tuesday's intraday session, several information technology stocks experienced significant movements. Gainers included Taoping (TAOP), UTime (UTME), BIT Mining (BTCM), Applied Optoelectronics (AAOI), Minim (MINM), and LightPath Technologies (LPTH). Losers included Mobilicom (MOB), MicroCloud Hologram (HOLO), CalAmp (CAMP), FOXO Technologies (FOXO), Gorilla Tech Gr (GRRR), and Powerbridge Technologies (PBTS).

Portfolio Pulse from Benzinga Insights

July 11, 2023 | 5:37 pm

Craig-Hallum analyst Anthony Stoss maintains a 'Buy' rating on CalAmp (NASDAQ:CAMP) but has lowered the price target from $4 to $2.

Portfolio Pulse from Benzinga Newsdesk

July 11, 2023 | 3:12 pm

CalAmp Corp. reported a loss for Q1 and issued a weak revenue forecast for Q2, causing its shares to fall 1.9%. Byrna Technologies is expected to post quarterly earnings of 1 cent per share on revenue of $12 million. Iovance Biotherapeutics priced its public offering of 20 million shares at $7.50 per share, leading to a 9.9% drop in its shares. WD-40 Company reported better-than-expected Q3 results and announced a 50 million share buyback program, causing its shares to gain 4.1%. VOXX International Corporation reported downbeat Q3 results, leading to a 12.8% dip in its shares.

Portfolio Pulse from Lisa Levin

July 11, 2023 | 8:16 am

CalAmp expects its Q2 FY24 revenues to range between $67 million and $73 million, which is lower than the estimated $77.14 million. The company also anticipates adjusted EBITDA to be between $5 million and $9 million. Due to the uncertainty and potential variability of future expenses, a reconciliation of non-GAAP guidance financial measures to corresponding GAAP guidance financial measures is not available.

Portfolio Pulse from Happy Mohamed

July 10, 2023 | 8:10 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.